Bilateral endogenous serratia marcescens endophthalmitis secondary to endocarditis following cardiac surgery

Scottish Medical Journal

Volumn 58, Issue 2, 2013, Pages

  Lyall, D A M ^a   Gregory, M E ^b   McDonnell, J ^c   De Villiers, F ^d   Tejwani, D ^d  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b STOBHILL HOSPITAL   (United Kingdom)

^c SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^d INVERCLYDE ROYAL HOSPITAL   (United Kingdom)

Author keywords

Blood ocular barrier; Endocarditis; Endogenous endophthalmitis; Intraocular inflammation; Serratia marcescens

Indexed keywords

ACETAZOLAMIDE; AMIKACIN; APRACLONIDINE; CEFTAZIDIME; CIPROFLOXACIN; DEXAMETHASONE; GENTAMICIN; LATANOPROST; MANNITOL; MEROPENEM; PREDNISOLONE;

AGED; ANISOCORIA; AORTA ANEURYSM; AORTA VALVE STENOSIS; ARTICLE; BENTALL PROCEDURE; CASE REPORT; CHEMOSIS; CORONARY ARTERY BYPASS GRAFT; DIFFERENTIAL DIAGNOSIS; ENDOCARDITIS; ENDOPHTHALMITIS; EXOPHTHALMOS; EYELID DISEASE; FEMALE; HEART SURGERY; HUMAN; HYPOPYON; INFLAMMATION; IRIDOCYCLITIS; OUTCOME ASSESSMENT; SERRATIA INFECTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 84890132036     PISSN: 00369330     EISSN: None     Source Type: Journal    
DOI: 10.1177/0036933013482647     Document Type: Article

References (29)

1. Jackson TL, Eykyn SJ, Graham EM, et al. Endogenous bacterial endophthalmitis: A 17-year prospective series and review of 267 reported cases. Surv Ophthalmol 2003; 48: 403-423.
2. Jacoby GA and Munoz-Price LS. The new beta-lactamases. N Engl J Med 2005; 352: 380-391.
3. Koul S, Philipson A and Philipson BT. Incidence of endophthalmitis in Sweden. Acta Ophthalmol (Copenh) 1989; 67: 499-503.
4. Shrader SK, Band JD, Lauter CB, et al. The clinical spectrum of endophthalmitis: Incidence, predisposing factors and features influencing outcome. J Infect Dis 1990; 162: 115-120.
5. Okada AA, Johnson RP, Liles WC, et al. Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Ophthalmology 1994; 101(5): 832-886.
6. Greenwald MJ, Wohl LG and Sell CH. Metastatic bacterial endophthalmitis: A contemporary reappraisal. Surv Ophthalmol 1986; 31(2): 81-101.
7. Chee SP and Jap A. Endogenous endophthalmitis. Curr Opin Ophthalmol 2001; 12(6): 464-470.
8. Wilkowske CJ, Washington JA, Martin WJ, et al. Serratia marcescens: Biochemical characteristics, antibiotic susceptibility patterns and clinical significance. JAMA 1970; 214: 2157-2162.
9. Jones RN. Important and emerging beta-lactamasemediated resistances in hospital-based pathogens: The Amp C enzymes. Diagn Microbiol Infect Dis 1998; 31: 461-466.
10. Suri RK, Selby DA, Hawks GH, et al. Serratia marcescens endocarditis. A report of a case involving Cross- Jones mitral valve prosthesis, with a review of the literature. Can Med Assoc J 1971; 104: 1013-1014.
11. Cooper R and Mills J. Serratia endocarditis: A follow-up report. Arch Intern Med 1980; 140: 19-202.
12. Orita H, Shimanuki T, Fukasawa M, et al. A clinical study of postoperative infections following open-heart surgery: occurrence and micro-biological findings in 782 cases. Surg Today 1992; 22: 207-212.
13. Dismukes WE, Karchmer AW, Buckley MJ, et al. Prosthetic valve endocarditis. Analysis of 38 cases. Circulation 1973; 48: 365-377.
14. Lockey E, Gonzalez-Lavin L, Ray I, et al. Bacteremia after open-heart surgery. Thorax 1973; 28: 183-187.
15. Jubair KA, Al Fagih MR, Ashmeg A, et al. Cardiac operations during active endocarditis. J Thorac Cardiovasc Surg 1992; 104: 487-490.
16. Atlee WE, Burns RP and Oden M. Serratia marcescens keratoconjunctivitis. Am J Ophthalmol 1970; 70: 31-33.
17. Cohen SM, Flynn Jr HW and Miller D. Endophthalmitis caused by Serratia marcescens. Ophthalmic Surg Lasers 1997; 28: 195-200.
18. Donnenfeld ED, Schrier A, Perry HD, et al. Infectious keratitis with corneal perforation associated with corneal hydrops and contact lens wear in keratoconus. Br J Ophthalmol 1996; 80(5): 409-412.
19. Binder MI, Chua J, Kaiser PK, et al. Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center. Medicine (Baltimore) 2003; 82: 97-105.
20. Keswani T, Ahuja V and Changulani M. Evaluation of outcome of various treatment methods for endogenous endophthalmitis. Indian J Med Sci 2006; 60: 454-460.
21. Okhravi N, Adamson P, Carroll N, et al. PCR-based evidence of bacterial involvement in eyes with suspected intraocular infection. Invest Ophthalmol Vis Sci 2000; 41: 3474-3479.
22. Lohmann CP, Linde HJ and Reischi U. Improved detection of microorganisms by polymerase chain reaction in delayed endophthalmitis after cataract surgery. Ophthalmology 2000; 107: 1047-1051.
23. Livermore D M and Brown DF. Detection of beta-lactamasemediated resistance. JAntimicrobChemother 2001; 48: 59-64.
24. Campochiaro PA and Conway BP. Aminoglycoside toxicity - a survey of retinal specialists. Implications for ocular use. Arch Ophthalmol 1991; 109: 946-950.
25. Campochiaro PA and Lim JI. Aminoglycoside toxicity in the treatment of endophthalmitis. The Aminoglycoside Toxicity Study Group. Arch Ophthalmol 1994; 112: 48-53.
26. Doft BH and Barza M. Ceftazidime or amikacin: Choice of intravitreal antimicrobials in the treatment of postoperative endophthalmitis. Arch Ophthalmol 1994; 112: 17.
27. Sakamoto H, Sakamoto M, Hata Y, et al. Aqueous and vitreous penetration of levofloxacin after topical and/or oral administration. Eur J Ophthalmol 2007; 17: 372.
28. Equi RA and Green WR. Endogenous Serratia marcescens endophthalmitis with dark hypopyon: Case report and review. Surv Ophthalmol 2001; 46: 259.
29. The Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995; 113: 1479.